Acute dystonia vs tardive dyskinesia: early spasm or late involuntary movement

Days versus months: the timing cue

Acute dystonia is an early reaction to dopamine blockade. Most cases begin within the first few days of starting an antipsychotic or after a significant dose increase. Other dopamine-blocking drugs, such as metoclopramide, can cause it too. Younger age and older high-potency agents are commonly cited risk factors. Ask about every recent dose change, including medicines given in an emergency department.

Tardive dyskinesia, as its name suggests, is late. It usually develops after months or years of treatment, though it can appear after a few weeks, and it may emerge or worsen when the drug is reduced or stopped. Risk rises with long-term, higher-dose exposure, older age and diabetes. A long medication history is the key context.

What each movement looks like

Dystonia is sustained or intermittent muscle contraction producing abnormal postures: the neck twisting to one side, the eyes deviating upwards in an oculogyric crisis, the jaw locking, the tongue protruding or the back arching. The patient is conscious and frightened, which helps distinguish it from a seizure. Laryngeal dystonia can obstruct the airway. Spasms can be painful and may come and go over hours if untreated.

Tardive dyskinesia produces repetitive, purposeless movements, most often around the mouth and face: chewing, lip smacking, tongue thrusting, grimacing and rapid blinking. Finger movements like piano playing, trunk rocking or pelvic thrusting may occur. The movements are not usually painful, and the patient may be less aware of them than family or staff. Ask family members what they have noticed, because they often see the movements first.

Responding to acute dystonia

Treat acute dystonia as urgent. Assess the airway first, because laryngeal involvement may present as stridor, difficulty speaking or breathing difficulty; call for emergency help if the airway is compromised. Notify the prescriber and give an anticholinergic such as benztropine or diphenhydramine as prescribed. Response is usually rapid, often within minutes.

Stay with the patient, explain what is happening and provide reassurance, since the experience is distressing and can damage trust in treatment. Anticholinergic therapy is often continued for a short period afterwards to prevent recurrence, and the antipsychotic plan may be reviewed. Document the reaction clearly so future prescribers are aware.

Responding to tardive dyskinesia

Tardive dyskinesia needs prompt reporting rather than an emergency response. Early recognition gives the best chance of improvement, and the prescriber may reduce, change or gradually stop the causative drug. Stopping suddenly is not a nursing decision, because relapse of psychosis is a serious risk and movements can worsen during withdrawal. Explain to the patient why changes are made gradually so that adherence is not undermined.

The VMAT2 inhibitors valbenazine and deutetrabenazine are approved treatments, and the prescriber may also review the antipsychotic itself. Anticholinergics, unlike in dystonia, may make tardive dyskinesia worse, which is a common exam trap. Assess movements regularly in anyone on long-term antipsychotics using the structured scale your service uses, and support patients who feel self-conscious about visible movements.

Worked scenario: two patients on haloperidol

Imagine a hypothetical 22-year-old who received his first doses of haloperidol yesterday. He is now holding his head twisted to the left, his eyes are rolled upwards and his voice sounds strained. Options include documenting a likely seizure, giving the next scheduled antipsychotic dose, reassessing at the end of the shift, or checking the airway and notifying the prescriber for anticholinergic treatment.

The last option is correct: he is alert, the timing fits acute dystonia, and a strained voice raises concern about the larynx. Compare a hypothetical 64-year-old on haloperidol for eight years who chews and pushes her tongue out repeatedly. She needs a structured movement assessment and a report to the prescriber, not benztropine. The exam is testing timing, appearance and urgency together.

Sources and further reading

MSD Manual Professional: Antipsychotic Medications. Acute dystonic reactions such as oculogyric crisis and torticollis treated with benztropine or diphenhydramine; cumulative tardive dyskinesia risk, regular monitoring and approved VMAT2 inhibitors valbenazine and deutetrabenazine.

PMC: Overview of Movement Disorders Secondary to Drugs. Tardive dyskinesia onset, orofacial movements, risk factors, VMAT2 inhibitors first line, anticholinergics may worsen it, and regular screening.

MedlinePlus: Tardive dyskinesia. Onset after months or years or as little as six weeks, typical movements, possible permanence after stopping and VMAT2 treatment.